The syringe with drugs for chemotherapy treatment

by Paul Fassa
Health Impact News

A new study published this month (July 2017) confirms what most who are not entrenched in mainstream oncology’s viewpoint of cancer treatment by chemo drugs have already pointed out: Chemo drugs are carcinogenic, and they actually cause cancer.

This is actually the second study published in modern times showing that the very drugs prescribed for cancer treatment, actually cause cancer.

The first study in 2012 didn’t raise much of a mainstream media stir, but the most recent study in 2017  made it into London, England’s mainstream press. This recent coverage also referenced the earlier 2012 study to further put the situation into perspective.

The 2017 media press coverage also rode on the coat tails of a recently publicized study showing that too many cancer patients in England were dying from chemo and not their cancers.

Commentary on the Studies

The 2017 study was conducted in New York City’s Albert Einstein College of Medicine of Yeshiva University. From their animal study abstract using breast cancer cells:

“Groups of cells collectively known as tumor microenvironment of metastasis (TMEM) can serve as gateways for tumor cells entering the vasculature, and the authors discovered that several types of chemotherapy can increase the amounts of TMEM complexes and circulating tumor cells in the bloodstream.” (Study Abstract)

This study also disclosed that even while shrinking existing tumors, many chemotherapy drugs increased the metastatic potential of breast cancer cells spreading to other organs. Their survival of chemo drugs would then make future cancers in other organs more difficult to treat because they’ve developed a resistance to those drugs.

The researchers interviewed wanted to make sure everyone continues with their chemo for breast cancer. They claim to have discovered pharmaceutical drugs that might impede the metastatic process they discovered from using chemo drugs.

The Albert Einstein researchers intend to do further studies of this nature for other cancers. For now they suggest getting biopsy tissues as the chemo treatments progresses to determine if any of those TMEM pathways are being created. Perhaps those other chemicals can be added to hopefully prevent metastasis or lower the chemo dosage.

The 2012 study was conducted at the Human Biology Division at the Fred Hutchinson Cancer Research Center in Seattle. It was originally published online in the journal Nature Medicine on August 6th, 2012.

The researchers examined cancer cells from prostate, breast and ovarian cancer patients who had been treated with chemotherapy. They discovered when the DNA of fibroblasts near the tumor are damaged by chemotherapy, they start producing a unique protein in the microenvironment of the tumor, which when reaching a higher level causes chemo resistant cancers to grow and invade surrounding tissue.

This research determined that toxic interventions of prostate, breast, and ovarian cancer cause DNA tissue damage to create a tumor microenvironment of metastasis or TMEM. The concern was the same as the 2017 study. Cancer cells that survived and/or spread to other organs would be more resistant to treatments of chemo or radiation. (Study pdf)

However, judging from comments from both study authors, these are simply efforts to find a way to keep administering expensive toxic chemotherapy drugs instead of finding ways to stop using them.

Holistic oncologist, the late Dr. Glenn Warner, M.D. explained:

“We have a multi-billion dollar industry that is killing people, right and left, just for financial gain. Their idea of research is to see whether two doses of this poison is better than three doses of that poison.” (Source)

And this reluctance to let it all go and seek natural cures is not merely subservience to Big Pharma’s expensive toxic drugs and the private and governmental insurance industries’ willingness to pay for them. Chris Wark of was curious when his oncologist kept trying to push him into chemo for his stage 3 colon cancer. He investigated and discovered:

“Their business model is very different from other doctors because you can’t buy chemotherapy drugs at your local pharmacy. Oncologists buy these drugs direct at wholesale prices, then they mark them up and bill the insurance companies. This legal profiting on drugs by doctors is unique to the cancer treatment world. They’re making money off the drugs that they insist you take to save your life. That’s a HUGE conflict of interest.”

You may read or hear that chemotherapy has an excellent track record of remission for blood cancers. Maybe so, but it’s not permanent. Dr. John Diamond, M.D., asserts:

A study of over 10,000 patients shows clearly that chemo’s supposedly strong track record with Hodgkin’s disease [lymphoma] is actually a lie. Patients who underwent chemo were 14 times more likely to develop leukemia and 6 times more likely to develop cancers of the bones, joints, and soft tissues than those patients who did not undergo chemotherapy. (Source)

Chemo May Kill You First Before it Can Develop More Cancer

Remember the British study mentioned earlier that seemed to open the mainstream media door to mainstream oncology criticism in England? It was published in a 2016 Lancet issue, one of the world’s most prestigious medical journals.

This study examined medical records of:

“… all women with breast cancer and all men and women with lung cancer residing in England, who were 24 years or older and who started a cycle of SACT [Systemic Anti-Cancer Therapy] in 2014 irrespective of the number of previous treatment cycles or programmes, and irrespective of their position within the disease trajectory.”

What they focused on was the 30 day mortality or death rate of thousands of patients receiving chemotherapy. This indicates death by treatment more than death from cancer. The study determined that out of 23,000 women with breast cancer and nearly 10,000 men with non-small cell lung cancer, 1,383 died within 30 days. The chemo killed them. (Study abstract)

Of course there could be many others who die from chemotherapy treatments instead of cancer beyond the 30 day mortality period. This time limitation simply makes it more evident that the cancer did not create those deaths, they were iatrogenic (caused by medical interventions).

Ironically, even the National Cancer Institute (NCI) reported in 2013 that mainstream oncology’s zealous over-diagnosis of non-malignant tumors was creating a dangerous burden of suffering for many coerced into chemotherapy and/or radiation unnecessarily.

Medscape reported on that study stating:

“The practice of oncology in the United States is in need of a host of reforms and initiatives to mitigate the problem of overdiagnosis and overtreatment of cancer, according to a working group sanctioned by the National Cancer Institute.” (Source)

The almost four decade mainstream medical and governmental “War on Cancer” has been lost, but it persists in order to protect the cancer industry as a lucrative endeavor regardless of the harm it creates. A combination of inordinate fear is used to coerce cancer patients into insanely expensive toxic treatments that medical insurance will accommodate.

Many do not have the financial wherewithal to cover safer, more effective, and even much less expensive treatments, some of which exist successfully only outside the U.S. in Mexico and other foreign nations, particularly in Europe.

Protecting the lucrative cancer industry, which includes highly profitable research funding groups, oncologists, and of course Big Pharma, involves threatening licensed M.D.s who use or discover better and safer means of treating cancer while claiming the hundreds of known alternative protocols don’t work at all.

Their “proof” is the lack of peer reviewed published studies for alternative methods and the FDA’s lack of approval for their protocols. But they are all involved in a corrupt effort to keep the lucrative cancer industry alive regardless of its toll on human health. (Source)

The following video of an interview of the late Dr. Nicholas Gonzalez is a must-watch for all the information you need to know about conventional therapy vs alternative therapy.

We Lost the War on Cancer – Review of Alternative Cancer Therapies

Retail :

Now : $599

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it in Part I. In Part II, he surveys the various alternative cancer therapies that have been proven effective, but that are not approved by the FDA.

Read We Lost the War on Cancer – Review of Alternative Cancer Therapies on your mobile device!

Order Here